The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| TEV | N/A | N/A | N/A | N/A |
| S&P | +13.95% | +78.35% | +12.25% | N/A |
Teva Pharmaceutical Industries Ltd. engages in the development, production, and sale of medicines. It operates through the following geographical segments: North America, Europe, and International Markets. The company was founded in 1901 and is headquartered in Tel Aviv, Israel.
No news articles found for Teva Pharmaceutical Industries.
| Q4 2025 | YOY Change | |
|---|---|---|
| Revenue | $4.06B | 3.2% |
| Gross Profit | $2.29B | 17.2% |
| Gross Margin | 56.49% | 6.7% |
| Market Cap | $30.28B | 24.7% |
| Market Cap / Employee | $907.95K | 0.0% |
| Employees | 33.3K | -7.8% |
| Net Income | $412.40M | 260.0% |
| EBITDA | $1.32B | 22.2% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q4 2025 | YOY Change | |
|---|---|---|
| Net Cash | $3.03B | -5.0% |
| Accounts Receivable | $3.16B | 6.9% |
| Inventory | 2.7K | -6.8% |
| Q4 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $13.01B | -17.4% |
| Short Term Debt | $1.63B | -9.6% |
| Q4 2025 | YOY Change | |
|---|---|---|
| Return On Assets | 3.40% | 7.3% |
| Return On Invested Capital | -6.04% | -0.9% |
| Q4 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | $1.31B | 72.9% |
| Operating Free Cash Flow | $1.44B | 61.8% |
| Metric | Q3 2025 | Q4 2025 | YoY Change | ||
|---|---|---|---|---|---|
| Price to Earnings | 32.53 | 25.08 | - | ||
| Price to Book | 3.07 | 2.82 | 3.22 | 4.91 | 9.90% |
| Price to Sales | 1.07 | 1.09 | 1.32 | 2.04 | 29.37% |
| Price to Tangible Book Value | -1.16 | -1.32 | -1.66 | -2.82 | 54.09% |
| Price to Free Cash Flow TTM | 8.50 | 14.59 | 65.89 | 36.37 | 186.12% |
| Enterprise Value to EBITDA | 34.71 | 28.45 | 29.03 | 32.29 | -9.82% |
| Free Cash Flow Yield | 11.8% | 6.9% | 1.5% | 2.7% | -65.05% |
| Return on Equity | -18.9% | -2.5% | 10.7% | 20.7% | -181.97% |
| Total Debt | $15.68B | $14.93B | $14.53B | $14.64B | -16.57% |
No podcast episodes available.
No transcripts available.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
